US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist
  • 10.690
  • +0.470+4.60%
Close Jul 22 16:00 ET
720.74MMarket Cap-5938P/E (TTM)

Oric Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.90%28.99M
27.68%110.78M
42.09%31.43M
38.60%28.68M
20.76%24.99M
10.41%25.68M
10.01%86.77M
-3.01%22.12M
12.13%20.69M
-1.71%20.7M
Selling and administrative expenses
14.09%7.03M
2.08%25.61M
19.28%6.95M
5.41%6.29M
-9.57%6.21M
-4.17%6.16M
13.96%25.09M
-3.89%5.82M
7.45%5.97M
23.86%6.86M
-General and administrative expense
14.09%7.03M
2.08%25.61M
19.28%6.95M
5.41%6.29M
-9.57%6.21M
-4.17%6.16M
13.96%25.09M
-3.89%5.82M
7.45%5.97M
23.86%6.86M
Research and development costs
12.52%21.96M
38.09%85.17M
50.24%24.48M
52.06%22.39M
35.80%18.79M
15.97%19.52M
8.48%61.68M
-2.69%16.3M
14.14%14.72M
-10.85%13.83M
Operating profit
-12.90%-28.99M
-27.68%-110.78M
-42.09%-31.43M
-38.60%-28.68M
-20.76%-24.99M
-10.41%-25.68M
-10.01%-86.77M
3.01%-22.12M
-12.13%-20.69M
1.71%-20.7M
Net non-operating interest income expense
Other net income (expense)
129.60%3.98M
528.15%10.08M
143.55%3.1M
177.48%3.2M
400.73%2.05M
1.73M
-15,800.00%-2.36M
1.27M
-4.14M
2,626.67%409K
Special income (charges)
----
--0
--0
--0
----
----
---5M
--0
---5M
----
-Less:Other special charges
----
----
----
----
----
----
--5M
--0
--5M
----
Other non- operating income (expenses)
129.60%3.98M
281.21%10.08M
143.55%3.1M
270.40%3.2M
400.73%2.05M
--1.73M
17,533.33%2.65M
--1.27M
--865K
2,626.67%409K
Income before tax
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
Income tax
Net income
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
Net income continuous Operations
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
Minority interest income
Net income attributable to the parent company
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
Basic earnings per share
30.19%-0.37
12.89%-1.96
3.85%-0.5
30.16%-0.44
1.96%-0.5
10.17%-0.53
-8.70%-2.25
10.34%-0.52
-34.04%-0.63
10.53%-0.51
Diluted earnings per share
30.19%-0.37
12.89%-1.96
3.85%-0.5
30.16%-0.44
1.96%-0.5
10.17%-0.53
-8.70%-2.25
10.34%-0.52
-34.04%-0.63
10.53%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.90%28.99M27.68%110.78M42.09%31.43M38.60%28.68M20.76%24.99M10.41%25.68M10.01%86.77M-3.01%22.12M12.13%20.69M-1.71%20.7M
Selling and administrative expenses 14.09%7.03M2.08%25.61M19.28%6.95M5.41%6.29M-9.57%6.21M-4.17%6.16M13.96%25.09M-3.89%5.82M7.45%5.97M23.86%6.86M
-General and administrative expense 14.09%7.03M2.08%25.61M19.28%6.95M5.41%6.29M-9.57%6.21M-4.17%6.16M13.96%25.09M-3.89%5.82M7.45%5.97M23.86%6.86M
Research and development costs 12.52%21.96M38.09%85.17M50.24%24.48M52.06%22.39M35.80%18.79M15.97%19.52M8.48%61.68M-2.69%16.3M14.14%14.72M-10.85%13.83M
Operating profit -12.90%-28.99M-27.68%-110.78M-42.09%-31.43M-38.60%-28.68M-20.76%-24.99M-10.41%-25.68M-10.01%-86.77M3.01%-22.12M-12.13%-20.69M1.71%-20.7M
Net non-operating interest income expense
Other net income (expense) 129.60%3.98M528.15%10.08M143.55%3.1M177.48%3.2M400.73%2.05M1.73M-15,800.00%-2.36M1.27M-4.14M2,626.67%409K
Special income (charges) ------0--0--0-----------5M--0---5M----
-Less:Other special charges --------------------------5M--0--5M----
Other non- operating income (expenses) 129.60%3.98M281.21%10.08M143.55%3.1M270.40%3.2M400.73%2.05M--1.73M17,533.33%2.65M--1.27M--865K2,626.67%409K
Income before tax -4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M3.44%-20.29M
Income tax
Net income -4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M3.44%-20.29M
Net income continuous Operations -4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M3.44%-20.29M
Minority interest income
Net income attributable to the parent company -4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M3.44%-20.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M3.44%-20.29M
Basic earnings per share 30.19%-0.3712.89%-1.963.85%-0.530.16%-0.441.96%-0.510.17%-0.53-8.70%-2.2510.34%-0.52-34.04%-0.6310.53%-0.51
Diluted earnings per share 30.19%-0.3712.89%-1.963.85%-0.530.16%-0.441.96%-0.510.17%-0.53-8.70%-2.2510.34%-0.52-34.04%-0.6310.53%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg